1. Xanthophyll β‐Cryptoxanthin Inhibits Highly Refined Carbohydrate Diet–Promoted Hepatocellular Carcinoma Progression in Mice
- Author
-
Lynne M. Ausman, Dayong Wu, Kang-Quan Hu, Ji Ye Lim, Xiang-Dong Wang, Chun Liu, Stefania Lamon-Fava, and Donald Smith
- Subjects
Male ,0301 basic medicine ,Vitamin ,Retinyl Esters ,medicine.medical_specialty ,Oxygenase ,Carcinoma, Hepatocellular ,medicine.medical_treatment ,Beta-Cryptoxanthin ,Intraperitoneal injection ,Apoptosis ,Carbohydrate metabolism ,Dioxygenases ,03 medical and health sciences ,chemistry.chemical_compound ,Lactate dehydrogenase ,Internal medicine ,Dietary Carbohydrates ,Tumor Microenvironment ,medicine ,Animals ,Vitamin A ,beta-Carotene 15,15'-Monooxygenase ,Mice, Knockout ,030109 nutrition & dietetics ,Body Weight ,Liver Neoplasms ,Carbohydrate ,Hypoxia-Inducible Factor 1, alpha Subunit ,medicine.disease ,Mice, Inbred C57BL ,Glucose ,030104 developmental biology ,Endocrinology ,chemistry ,Hepatocellular carcinoma ,Dietary Supplements ,Tumor Hypoxia ,Diterpenes ,Tumor Suppressor Protein p53 ,Steatosis ,Glycolysis ,Food Science ,Biotechnology - Abstract
Scope β-Cryptoxanthin (BCX) can be cleaved by both β-carotene 15,15'-oxygenase (BCO1) and β-carotene 9',10'-oxygenase (BCO2), generating biological active vitamin A and apocarotenoids. We examined whether BCX feeding could inhibit diethylnitrosamine (DEN)-initiated, highly refined carbohydrate diet (HRCD)-promoted hepatocellular carcinoma (HCC) development, dependent or independent of BCO1/BCO2 activity. Methods and results Two-week-old male wild-type (WT) and BCO1-/- /BCO2-/- double knockout (DKO) mice are given a single intraperitoneal injection of DEN (25 mg kg-1 body weight) to initiate hepatic carcinogenesis. At 6 weeks of age, all animals are fed HRCD (66.5% of energy from carbohydrate) with or without BCX for 24 weeks. BCX feeding increases hepatic vitamin A levels in WT mice, but not in DKO mice that shows a significant accumulation of hepatic BCX. Compared to their respective HRCD littermates, both WT and DKO fed BCX have significantly lower HCC multiplicity, average tumor size, and total tumor volume, and the steatosis scores. The chemopreventive effects of BCX are associated with increased p53 protein acetylation and decreased protein levels of lactate dehydrogenase and hypoxia-inducible factor-1α in tumors. Conclusion This study suggests that BCX feeding may alleviate HRCD-promoted HCC progression by modulating the acetylation of p53, hypoxic tumor microenvironment, and glucose metabolism, independent of BCO1/BCO2.
- Published
- 2020
- Full Text
- View/download PDF